Lafutidine
Sponsors
Wakayama Medical University, Taiho Pharmaceutical Co., Ltd., Boryung Pharmaceutical Co., Ltd, Canadian Network for Observational Drug Effect Studies, CNODES, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Conditions
Chronic GastritisCommunity-acquired PneumoniaErosive EsophagitisGastric UlcerGastroesophageal RefluxGastroesophageal Reflux Disease (GERD)Mild gastroesophageal reflux diseasePeptic Ulcer
Phase 1
The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers
CompletedNCT02581696
Start: 2015-08-31End: 2015-11-30Updated: 2017-02-06
Pharmacokinetic Properties and Effect of Food on Pharmacokinetic Properties of the Oral Lafutidine Tablets
CompletedNCT02658864
Start: 2005-04-30End: 2005-06-30Updated: 2016-01-20
A Study to Compare the Pharmacokinetics of Lafutidine and Irsogladine Maleate Tablet
CompletedNCT02759224
Start: 2016-04-15End: 2016-12-29Updated: 2017-02-07
Phase 2
Phase 3
Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine -
CompletedNCT00229424
Start: 2005-04-30End: 2007-01-31Target: 325Updated: 2011-07-07
A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis Patients
CompletedNCT01499368
Start: 2011-11-30End: 2012-11-30Updated: 2025-01-15